In this study, for the first time, we report five oncogenes (TUBA1B, SLC2A1, PGK1, CCND1, and NCAPD2) and two tumor suppressors’ genes (RPLP2, RPL37) as novel therapeutic targets in breast cancer. Here, SLC2A1 is linked to breast carcinoma.